ETF Holdings Breakdown of TMO

Stock Name	Time Out Group plc
Ticker	TMO(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	GB00BYYV0629
LEI	213800BWH4OF8S4R8K10

TMO institutional holdings

The following institutional investment holdings of TMO have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2026-02-09	IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc))	57	USD 31,165 0.7%	546.75
2026-02-09	IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF)	5,002	USD 2,734,894 0.7%	546.76
2026-02-09	IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc))	105,903 200.0%	USD 57,903,524 199.3%	546.76
2026-02-09	IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc))	16,383 0.7%	USD 8,957,569 1.4%	546.76
2026-02-09	IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc))	25,707	USD 14,055,559 0.7%	546.76
2026-02-09	IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist))	403,968 200.0%	USD 220,873,544 199.3%	546.76
2026-02-09	IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc))	199	USD 108,805 0.7%	546.76
2026-02-09	IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc))	126,521	USD 69,176,622	546.76
2026-02-09	IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist)	3,991	USD 2,182,119 0.7%	546.76
2026-02-09	IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc)	74	USD 40,460	546.76
2026-02-09	IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc))	54	USD 29,525 0.7%	546.76
2026-02-09	IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc))	16,383 0.7%	USD 8,957,569 1.4%	546.76
2026-02-09	IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist))	605,435	USD 331,027,641 0.7%	546.76
2026-02-09	IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc))	7,680	USD 4,199,117	546.76
2026-02-09	IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist))	54	USD 29,525 0.7%	546.76
2026-02-09	IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist))	57	USD 31,165 0.7%	546.75
2026-02-09	IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist))	128,605	USD 70,316,070	546.76
2026-02-09	IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD)	7,548	USD 4,126,944	546.76
2026-02-09	IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc))	9,463	USD 3,782,295	399.69
2026-02-09	IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc))	59,311	USD 27,222,567	458.98
2026-02-09	IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc))	2,537	USD 1,014,021 0.2%	399.69
2026-02-09	IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc))	191,805	USD 104,871,302	546.76
2026-02-09	IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc))	25,365	USD 11,642,029	458.98
2026-02-09	IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc))	605,435	USD 331,027,641 0.7%	546.76
2026-02-09	IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc))	21,928	USD 11,989,353	546.76
2026-02-09	IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc))	885,817 0.0%	USD 484,329,303 0.7%	546.76
2026-02-09	IE00B6R52259 (iShares MSCI ACWI UCITS ETF)	107,759	USD 58,918,311	546.76
2026-02-09	IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist))	605,435	USD 331,027,641	546.76
2026-02-09	IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist))	885,817 0.0%	USD 484,329,303 0.7%	546.76
2026-02-09	IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc))	126,521	USD 69,176,622	546.76
2026-02-09	IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist))	126,521 -0.1%	USD 69,176,622 0.6%	546.76
2026-02-09	IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF)	33,998	USD 18,588,746	546.76
2026-02-09	IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP)	7,555 -0.9%	USD 4,130,772 -0.2%	546.76
2026-02-09	IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP)	7,555 -0.9%	USD 4,130,772 -0.2%	546.76
2026-02-09	IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist))	45,246	USD 24,738,703	546.76
2026-02-09	IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF)	25,707	USD 14,055,559 0.7%	546.76
2026-02-09	IE00BKBF6H24 (iShares Core MSCI World UCITS ETF)	605,435	USD 331,027,641	546.76
2026-02-09	IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc))	885,817	USD 484,329,303	546.76
2026-02-09	IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF)	191,805 0.1%	USD 104,871,302 0.8%	546.76
2026-02-09	IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc))	403,968	USD 220,873,544	546.76
2026-02-09	IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc))	3,991	USD 2,182,119	546.76
2026-02-09	IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc))	3,048	USD 1,666,524 0.7%	546.76
2026-02-09	IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist))	3,048	USD 1,666,524 0.7%	546.76
2026-02-09	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	36,673	USD 20,051,329	546.76
2026-02-06	IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc))	107,759 0.3%	USD 58,494,818 -6.8%	542.83
2026-02-06	IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist))	38,649	USD 20,979,837 -7.2%	542.83
2026-02-06	IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist))	33,998 0.2%	USD 18,455,134 -7.0%	542.83
Total =	7,541,587	USD 4,113,531,454

News associated with TMO

Guru Fundamental Report for TMO: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-18 10:39:11
TMO Factor-Based Stock Analysis: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-17 10:34:46
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
Validea Detailed Fundamental Analysis - TMO: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-12 10:32:52
Guru Fundamental Report for TMO: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-11 10:33:22
TMO Factor-Based Stock Analysis: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-10 10:34:15
TMO Quantitative Stock Analysis: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-09 10:34:36
Guru Fundamental Report for TMO: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-04 10:32:26
Thermo Fisher Scientific (NYSE:TMO) CEO Marc Casper Sells 10,000 Shares: Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report) CEO Marc Casper sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $500.96, for a total transaction of $5,009,600.00. Following the transaction, the chief executive officer directly owned 115,174 shares […] - 2025-08-28 05:22:48
Head to Head Review: Thermo Fisher Scientific (NYSE:TMO) and PROCEPT BioRobotics (NASDAQ:PRCT): Thermo Fisher Scientific (NYSE:TMO – Get Free Report) and PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership. Valuation & Earnings This table compares Thermo […] - 2025-08-25 04:26:46
Notable Wednesday Option Activity: TMO, DE, NKE: Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Thermo Fisher Scientific Inc (Symbol: TMO), where a total of 14,417 contracts have traded so far, representing approximately 1.4 million underlying shares. That amounts t - 2025-08-13 14:51:35
Thermo Fisher Scientific (NYSE:TMO) Rating Lowered to Hold at Wall Street Zen: Thermo Fisher Scientific (NYSE:TMO – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Sunday. TMO has been the subject of several other research reports. Argus lowered their price target on shares of Thermo Fisher Scientific from […] - 2025-08-12 02:40:48
Validea Detailed Fundamental Analysis - TMO: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-08-08 10:04:07
Thermo Fisher Scientific (NYSE:TMO) Shares Gap Up Following Better-Than-Expected Earnings: Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report)’s share price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $427.62, but opened at $473.26. Thermo Fisher Scientific shares last traded at $476.44, with a volume of 1,341,090 shares. The medical research […] - 2025-07-25 04:26:46
TMO Factor-Based Stock Analysis: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-23 10:34:47
Thermo Fisher Scientific Q2 25 Earnings Conference Call At 8:30 AM ET: (RTTNews) - Thermo Fisher Scientific (TMO) will host a conference call at 8:30 AM ET on July 23, 2025, to discuss Q2 25 earnings results. - 2025-07-23 08:30:30
Pre-Market Earnings Report for July 23, 2025 : T, NEE, GEV, BSX, TMO, APH, CME, FI, MCO, GD, FCX, HLT: The following companies are expected to report earnings prior to market open on 07/23/2025. Visit our Earnings Calendar for a full list of expected earnings releases.AT&T Inc. (T)is reporting for the quarter ending June 30, 2025. The wireless (national) company's consensus e - 2025-07-22 17:00:01
Validea Detailed Fundamental Analysis - TMO: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-18 10:34:50
TMO Factor-Based Stock Analysis: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-16 10:39:52
TMO Quantitative Stock Analysis: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-15 10:35:29
Thermo Fisher Scientific (NYSE:TMO) Upgraded by Scotiabank to “Sector Outperform” Rating: Scotiabank upgraded shares of Thermo Fisher Scientific (NYSE:TMO – Free Report) from a sector perform rating to a sector outperform rating in a research report report published on Friday morning, Marketbeat.com reports. They currently have $590.00 price target on the medical research company’s stock. TMO has been the subject of several other research reports. Robert […] - 2025-07-14 03:46:44
Validea Detailed Fundamental Analysis - TMO: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-11 10:32:18
Guru Fundamental Report for TMO: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-10 10:38:39
TMO Factor-Based Stock Analysis: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-09 10:32:57
TMO Quantitative Stock Analysis: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-08 10:34:57
Validea Detailed Fundamental Analysis - TMO: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-04 10:34:45
TMO Factor-Based Stock Analysis: Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-02 10:35:52
Notable ETF Inflow Detected - UPRO, HD, PEP, TMO: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro S&P 500 (Symbol: UPRO) where we have detected an approximate $234.1 million dollar inflow -- that's a 5.5% increase week over - 2025-06-30 11:52:15
Thermo Fisher Scientific (NYSE:TMO) and Masimo (NASDAQ:MASI) Head-To-Head Comparison: Thermo Fisher Scientific (NYSE:TMO – Get Free Report) and Masimo (NASDAQ:MASI – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings. Profitability This table compares Thermo Fisher Scientific and […] - 2025-06-27 02:38:48
Barclays Issues Pessimistic Forecast for Thermo Fisher Scientific (NYSE:TMO) Stock Price: Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price objective reduced by analysts at Barclays from $475.00 to $450.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price objective points to a potential upside of 9.64% from the […] - 2025-06-26 05:16:49

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.